Cargando…
The effect of atomoxetine on cognitive function in patients with multiple sclerosis
Background: Recent research shows that most of the patients with multiple sclerosis (MS) have cognitive-like disorders. Due to the beneficial effects of atomoxetine on improving cognition in limited animal and human surveys, the aim of the present study was to investigate the effect of the atomoxeti...
Autores principales: | Mohammadian Nejad, Ehsan, Amouzadeh, Effat, Kashipazha, Davood, Shamsaei, Gholamreza, Cheraghian, Bahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626139/ https://www.ncbi.nlm.nih.gov/pubmed/38011451 http://dx.doi.org/10.18502/cjn.v22i3.13792 |
Ejemplares similares
-
Evaluation of safety of rituximab in patients with multiple sclerosis: A retrograde study
por: Majdinasab, Nastaran, et al.
Publicado: (2020) -
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects
por: Hejazi, Ehsan, et al.
Publicado: (2014) -
Effects of N‐acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis
por: Khalatbari Mohseni, Golsa, et al.
Publicado: (2023) -
Solifenacin versus posterior tibial nerve stimulation for overactive bladder in patients with multiple sclerosis
por: Majdinasab, Nastaran, et al.
Publicado: (2023) -
A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran
por: Kashipazha, Davood, et al.
Publicado: (2015)